Evidence map›Paper›PMID 33123872›Full record

ArticleHuman cell2021

Analysis of microRNA regulating cell cycle-related tumor suppressor genes in endometrial cancer patients.

Łukasz Witek, Tomasz Janikowski, Iwona Gabriel, Piotr Bodzek, Anita Olejek

Open access · hybridAbstract read
In one paragraph

Article in Human cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. miR-874: An Important Regulator in Human Diseases.Frontiers in cell and developmental biology · 2022
    Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Łukasz WitekDepartment of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Bytom, Poland.
Tomasz JanikowskiSilesian College of Medicine, Katowice, Poland. tomekjanikowski24@gmail.com.ORCID http://orcid.org/0000-0001-8019-288X
Iwona GabrielDepartment of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Bytom, Poland.
Piotr BodzekDepartment of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Bytom, Poland.
Anita OlejekDepartment of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Bytom, Poland.
Medical University of Silesia · PLGórnośląska Wyższa Szkoła Handlowa im. Wojciecha Korfantego · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer remains the most common malignancy of the female genital system in developed countries. Tumor suppressor genes are responsible for controlling the cells fate in the cell cycle and preventing cancerogenesis. Gene expression affects cancer progression and is modulated by microRNAs defined as both tumor suppressors and oncogenes. These molecules indirectly regulate multiple processes like cell proliferation, differentiation and apoptosis. The aim of this study was to analyze miRNAs expression that can regulate the activity of tumor suppressor genes related to the cell cycle in patients with endometrioid endometrial cancer. The study group consisted of 12 samples that met the inclusion criteria from a total of 48 obtained. The 12 samples were used to analyze microRNA expression. Complementary miRNAs were identified using TargetScan Database and statistical analysis. MicroRNAs were determined for the tumor suppressor genes: CYR61, WT1, TSPYL5, HNRNPA0, BCL2L1 and BAK1. All the miRNAs were complementary to the described target genes based on TargetScan Database. There were five miRNAs differentially expressed that can regulate tumor suppressor genes related to the cell cycle. The distinguished miRNAs: mir-340-3p, mir-1236-5p, mir-874-3p, mir-873-5p.2 and mir-548-5p were differentially expressed in endometrial cancer in comparison to the control. Among the distinguished miRNAs, the most promising is mir-874-3p, which may have an important role in endometrial adenocarcinoma proliferation.

Indexed as

Genes, Tumor SuppressorAdenocarcinomaAgedCell CycleCell ProliferationCysteine-Rich Protein 61Endometrial NeoplasmsFemaleGene ExpressionGene Expression Regulation, NeoplasticHumansMicroRNAsMiddle AgedNuclear ProteinsWT1 ProteinsCCN1 protein, humanCysteine-Rich Protein 61MicroRNAsMIRN874 microRNA, humanNuclear ProteinsTSPYL5 protein, humanWT1 protein, humanWT1 ProteinsCancerCell cycleEndometrial cancerMicro RNATumor suppressor genes

Identifiers

PMID33123872
PMCPMC7900021
OpenAlexW3096663507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.